DOSING REGIMEN Application WO-2021079129-A1 World Intellectual Property Organisation (WIPO) 29 Apr 2021
Dosage regimen for sapacitabine and decitabine in combination for treating acute myeloid… Application US-10226478-B2 United States of America 12 Mar 2019
Dosing regimens for treatment of proliferative disorders comprising administration of… Grant US-9675631-B2 United States of America 13 Jun 2017
Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as… Grant US-8975239-B2 United States of America 10 Mar 2015
Combinations of sapacitabine or CNDAC with DNA methyltransferase inhibitors such as… Application US-8530445-B2 United States of America 10 Sep 2013
Combination comprising CNDAC (2′-cyano-2′-deoxy-N4-palmitoyl-1-beta-D-arabinofuranosyl-cyto… Application US-8349792-B2 United States of America 08 Jan 2013